抄録
We collected data on adverse reactions due to R-CHOP chemotherapy in our hospital from November 2005 to November 2006 from electronic clinical records and then conducted a retrospective analysis of adverse effect data for malignant lymphoma patients.The results of our survey for the first time R-CHOP therapy was administered indicated high incidences for infusion reactions (52.6%),constipation (71.6%),neutropenia (96.6%) and leukocytopenia (83.3%).Based on the results,we prepared a brochure entitled“Explanation of adverse effects of R-CHOP therapy”.The objectives of preparing the brochure were to minimize inter-individual differences between the pharmaceutical care and drug consultation provided by clinical pharmacists and ensure that patients had a good understanding of their treatment.We are sure that this kind of activity will help us to provide better pharmaceutical care for patients.
